MedPath

Clonazepam

Clonazepam Tablets, USP Rx only

Approved
Approval ID

1ce88d2c-70f7-427b-8787-4afd9ce6f71c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 5, 2023

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

clonazepam

PRODUCT DETAILS

NDC Product Code43063-788
Application NumberANDA077147
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 5, 2023
Generic Nameclonazepam

INGREDIENTS (6)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CLONAZEPAMActive
Quantity: 2 mg in 1 1
Code: 5PE9FDE8GB
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clonazepam - FDA Drug Approval Details